Clinical Applications of Spirometry for Pediatric Asthma

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Pulmonary Function Testing
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Academy Board Prep PCCM
Respiratory Function Tests RFTs
Respiratory Disease – Peak Flow Clinical Skills and Simulation Team Respiratory Disease Quiz – Peak Flow Clinical Skills Formative Quiz.
Physiology Lab Spirometry
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Spirometery. Lung Volumes 4 Volumes 4 Capacities Sum of 2 or more lung volumes IRV TV ERV RV IC FRC VC TLC RV.
LUNG FUNCTION IN HEALTH AND DISEASE: SPIROMETRY Sultan Ayoub Meo MBBS, PGC Med Ed, PG Dip Med Ed, M.Phil, Ph.D Professor, Department of Physiology, College.
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
Asthma What is Asthma ? V1.0 1997 Merck & ..
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Deep breath and blow - the HCA role in respiratory care
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Respiratory function tests
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Diagnosing asthma History & Physical examination Measurements of lung function – Spirometry – Peak expiratory flow Measurements of airway hyperresponsiveness.
Pulmonary function test By Maisa Mansour, MD. PFT PTF is one of the most important and most frequently utilized investigations in our field. Why do.
Respiratory Impairment and Disability A. H. Mehrparvar, M.D.
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
Spirometry (Pulmonary Function Tests)
1 Mosby items and derived items © 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Pulmonary Function Study Assessments Pulmonary Function.
Respiratory COPD/Asthma.
PULMONARY FUNCTION MEASUREMENTS MODULE D. Objectives At the completion of this module you will: List the four lung volumes including the following information:
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Pulmonary Function David Zanghi M.S., MBA, ATC/L, CSCS.
Pulmonary Function Testing (PFT)
Spirometry (Pulmonary Function Tests)
Pulmonary Function Measurements
Forced Vital Capacity. Forced Expiratory Volume in One Second. Obstructive Vs. Restrictive lung diseases. Pulmonary Function Test PFT.
Spirometry A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
Pulmonary Function Tests Eloise Harman. Symptoms of Lung Disease Cough, productive or unproductive Increased sensitivity to odors and irritants Pleuritic.
PULMONARY FUNCTION TESTING By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)
An Overview of Pulmonary Function Tests Norah Khathlan M.D. Consultant Pediatric Intensivist 10/2007.
Pulmonary Function Tests (PFTs)
Respiratory Function Tests RFTs. Review Of Anatomy & physiology Lungs comprised of  Airways  Alveoli.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
DYNAMIC SPIROMETER By Dr. Maha al-Enazy. Objectives To understand the different measurements of lung volume To learn how spirometer works and the different.
SPIROMETRY (Pulmonary Function Testing)
Dr. Taj. What is Spirometry ? It is a measurement of the breathing capacity of the lungs. It is the most basic and frequently performed test of pulmonary.
Maggie Harris Independent Respiratory Nurse Specialist
Clinical Application of Pulmonary Function Tests Sevda Özdoğan MD, Prof. Chest Diseases.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
What your test results mean to you and your doctor Emily Gilbert, MD Assistant Professor, Dept of Medicine Div of Pulmonary & Critical Care Loyola University.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Definition of asthma Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory.
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
The Spirometry 1 Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health –
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
A small device with great importance Presented by : Dr. Jalal Mohsin Uddin DTCD, FCPS (Pulmonology) Presented by : Dr. Jalal Mohsin Uddin DTCD, FCPS (Pulmonology)
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Pulmonary function tests & Lung volumes & capacities Prof. Omer Abdel Aziz.
Pulmonary Function Tests Pulmonary Function Tests Marcus A. Nesbeth PA-C June 19, 2009.
By: James Simpson.  Why  What – now featuring definitions  When  Interpretation  CA$H MONEY.
An Approach For Spirometry and DLCO Interpretation
Lung function in health and disease
Interpretation Normal Spirometry Obstructive pattern
PFT.
SPIROMETRY IN PRIMARY CARE
Spirometry A. H. Mehrparvar, MD Occupational Medicine department
Presentation transcript:

Clinical Applications of Spirometry for Pediatric Asthma Andi Marmor, MD Assistant Clinical Professor, Pediatrics University of California, San Francisco San Francisco General Hospital November 21, 2010

Goals and Objectives Goal: Improved comfort in performing and interpreting spirometry Objectives: Define FVC, FEV1, FEV1/FVC and FEF 25%-75% Recognize and describe the characteristic spirometry patterns of obstructive lung disease Interpret the results of a bronchodilator challenge Describe one way in which spirometry can impact the care of a patient with asthma

Outline I. Why do spirometry? II. Spirometry tools: What is measured? What do the measurements mean? III. Interpreting the results Quality of study Obstructive vs restrictive disease Reversibility IV. Application: Case studies

I. Why do Spirometry? Spirometry measures expiratory volume and airway flow during a forced expiration These numbers and the resultant expiratory flow diagram can help us estimate Strength and function of chest wall Lung size and compliance (“restrictive lung disease”) Airway size and patency (“obstructive lung disease” Asthma is a form of obstructive lung disease

Who Should Get Spirometry? General indications: Diagnosis of lung disease Screening for individuals at risk of lung disease Monitoring of response to treatments or exposures Preoperative assessments Disability evaluations Public health concerns

Who Should Get Spirometry? General indications: Diagnosis of lung disease Screening for individuals at risk of lung disease Monitoring of response to treatments or exposures Preoperative assessments Disability evaluations Public health concerns

Spirometry in Pediatric Asthma For Diagnosis Document presence and severity of airway obstruction Demonstrate reversibility of obstruction Document reactivity of obstruction For Monitoring Response to treatment Evidence of compliance Changes in disease severity over time

EPR-3 and Spirometry Recommended in adults and children >5 in whom diagnosis of asthma is being considered FEV1/FVC added to classification for asthma severity and control in children>5 and adults FEV1 can be used to follow lung growth

When should spirometry be done for asthma patients? At the time of initial diagnosis Document airflow obstruction Document reversibility When reducing the dosage of medications At least every 1 – 2 years in moderate to severe asthmatics

Who should NOT get spirometry? Inability to tolerate test Symptoms such as severe cough, nausea, vertigo Risk of damage from performing test Hemoptysis Pneumothorax Recent abdominal, thoracic or ocular surgery Recent MI Thoracic aneurysm

II. Tools for Interpreting Spirometry: What Are We Measuring? FVC, FEV1, FEV1/FVC, FEF 25-75% Reported as both absolute values and percent predicted “Percent predicted” Based on age, height Most useful in interpretation

FVC = Forced Vital Capacity

FVC Maximum volume expired during forced expiratory effort after maximum inhalation Normal = 80-120% of predicted Reduced in Conditions which reduce lung volumes Eg: restrictive lung disease (stiff lung, weak/stiff chest wall) or poor effort Should NOT be reduced in asthma

FEV1 = Forced Expiratory Volume in 1st Second

FEV1 Total volume expired in 1st second of forced expiratory effort after maximum inhalation Normal = 80-120% of predicted Reduced in Conditions which obstruct expiratory airway flow Eg: obstructive lung disease (asthma, COPD) or fixed obstruction (mass, foreign body) However, will be proportionately reduced in patients with low lung volumes as well!

FEV1/FVC = Percentage of FVC expired in the 1st second

FEV1/FVC Ratio One of the key tools for distinguishing diseases of airway obstruction from those of small lung volumes Especially important when FVC is reduced, as ratio corrects for low volumes May be reported as an absolute ratio, or as a percent of predicted In adults, normal ratio is 80% If reported as % predicted, normal is 100%

FEF 25-75%= Forced Expiratory FLOW from 25th to 75th % of FVC

FEF 25-75% Average expiratory flow rate over the middle 50% of the FVC What does this tell us? Sensitive measure of small airway obstruction Eliminates large airway emptying and beginning of expiration, and fatigue at the end Especially useful in pediatric asthma, and in mild obstruction

Peak Flow: The highest flow achieved at any point during the expiration

III. Interpreting Spirometry Is the test adequate? Does this patient have restrictive or obstructive lung disease? Is the obstruction reversible?

Orientation

1. Is it an adequate test? At least three adequate attempts Each expiration >6 seconds (3 sec for kids) Expiration should be smooth Largest FVC and FEV1 within 0.2 L (or 10% of predicted)

1. Is this an adequate study?

2. Obstructive or Restrictive Lung Disease? Abnormal spirometry may be indicative of 3 types of lung pathology Obstructive Restrictive Mixed obstructive/restrictive Keep in mind that that FVC and FEV1 are based on population norms The key is to identify a pattern suggesting one of the above pathologies

Pattern of Obstructive Lung Disease Hallmark: Obstruction to expiratory airway flow, usually from decreased airway size Examples: ASTHMA, COPD, fixed airway obstruction (airway mass/foreign body) FVC: FEV1: FEV1/FVC:

Pattern of Restrictive Lung Disease Hallmark: Loss of lung volume without airway obstruction Examples: interstitial lung disease, respiratory muscle weakness, thoracic wall deformities FVC: FEV1: FEV1/FVC:

Mixed Obstructive/Restrictive Obstruction to airflow AND reduced lung volumes Example: cystic fibrosis FVC: FEV1: FEV1/FVC:

Role of FEF 25-75% A very sensitive measure of airway obstruction Most useful when FEV1/FVC and FVC are normal If FEF 25-75 low, may be “small airway” obstruction Essential for diagnosis of mild persistent disease, especially in children

Interpretation Based on FEV1/FVC One of the key tools for distinguishing diseases of airway obstruction from those of small lung volumes Especially important when FVC is reduced, as ratio corrects for low volumes In restrictive lung disease? In obstructive lung disease? In mixed restrictive/obstructive?

Figure 2: Algorithm for Interpreting PFT’s in Asthma Patients Is FEV1/FVC > 80% predicted? Is FVC > 80% predicted? Restrictive Pattern ▪Further workup for confirmation & diagnosis Obstructive Airway Disease Is FEF 25-75% <80% predicted? Yes No Bronchodilator Response? (>15% improvement in FEV1) Small Airway Obstruction ▪Reversible if 15% improvement after bronchodilator Asthma ▪Determine severity based on symptoms and FEV1 Normal PFT Non-reversible obstruction ▪Recheck after ICS therapy ▪Consider other diagnoses Figure 2: Algorithm for Interpreting PFT’s in Asthma Patients

Visual Diagnosis A picture is worth a thousand words…

3. Reversibility Obstructive airway disease + reversibility = asthma Absence of reversibility DOES NOT rule out asthma Recheck after 1-3 months of inhaled corticosteroid

Bronchodilator challenge Inhaled albuterol or levalbuterol Patient has not had BD for 24 hours Perform spirometry 15-20 minutes after BD Positive if 15% increase in FEV1 OR 15% increase in FEF 25-75%

Obstructive airway disease (eg: asthma) before and after bronchodilator

Severe obstructive airway disease (eg: emphysema) before and after bronchodilator

IV. Case Studies Is the study adequate? Is there evidence of obstructive, restrictive lung disease or both? What is the response to bronchodilator? What has spirometry added to our understanding and management of the patient?

Case Study 1: DB 16 yo girl with a long history of poorly controlled asthma At her first visit, she reports no daytime or nighttime symptoms She is on no daily meds for her asthma, and reports infrequent use of albuterol

1. Is this an adequate study? 2. Does this patient have obstructive or restrictive lung disease?

3. Is it reversible?

Case Study 2: LR 10 yo girl who has been on daily Qvar for a month after a severe exacerbation Mother wishes to stop her daily medications since she is no longer coughing at night You perform spirometry pre- and post- bronchodilator

Would you stop her daily ICS?

Case Study 3: HC 8 yo boy recently discharged after an admission for asthma exacerbation Discharged on Qvar 40, 1 puff twice daily Reports daily symptoms requiring use of albuterol

Obstruction or restriction?

Reversible?

What would you do next?

After increase in dose of ICS for one month

Case Study 4: GV 16 yo girl whose symptoms of cough and shortness of breath are isolated to exercise She wishes to play on the soccer team, but feels that she is too “out of shape” to play Unclear if symptoms are due to asthma or poor conditioning

Exercise challenge

Review of Key Points Ensure an adequate study Look at FEV1/FVC ratio and FVC and to determine if obstructive or restrictive disease is present FEF 25-75% useful in cases of mild obstruction Reversibility confirms asthma

Thank you!